Skip to content
Use case · Investigator's Brochure

The IB, kept in sync with the evidence.

Asthra drafts ICH E6(R3) Appendix A–structured Investigator's Brochures from your nonclinical and clinical data. Toxicology margins, human pharmacokinetics, and the reference safety information stay consistent across subsections — and every update tracks as the program evolves.

IB draft in progress
Compound-XYZ-IB-v1.1.docx
3.2Summary486 wordsDone
5.1Nonclinical Pharmacology712 wordsDone
5.3Toxicology934 wordsDone
6.1Human Pharmacokinetics1 gap
6.2Clinical Safety & EfficacyDrafting
7.0Known & Potential Risks (RSI)Pending
ICH E6(R3)
Structured to Appendix A, with MedDRA terminology for adverse events.
Nonclinical → clinical
Toxicology-to-human dose margins reconciled in one synthesis.
100%
Of generated claims trace back to a writer-approved source.
What's new
For the IB, the studio capabilities that matter most are tables & figures in the chat for the nonclinical and PK summary tables, and end-of-run QC to keep the reference safety information consistent with the body of the brochure.
Inputs

What you bring to the draft.

Asthra works from the safety and pharmacology package your program has already generated.

PDF

Nonclinical Study Reports

Pharmacology and toxicology — single- and repeat-dose. Asthra extracts NOAELs, margins, and findings.

PDF

PK / ADME Data

Animal and human pharmacokinetics, metabolism, and popPK modeling for the effects-in-humans sections.

XLS

Clinical Safety Data

Prior Phase 1/2 exposure and adverse-event tables — coded to MedDRA, summarised by SOC and grade.

DOC

Prior IB Version

The last edition. Asthra tracks changes forward, flagging what regulatory feedback has moved.

PDF

Mechanism / Literature

Mechanism of action and comparator data informing the introduction and risk context.

DOC

Your IB Template

Asthra writes into your house template — numbering, headings, and summary tables preserved.

Workflow

From the safety package
to a synchronised brochure.

01

Upload & classify

Drop your nonclinical reports, PK data, clinical safety tables, and the prior IB into the project. Asthra classifies and indexes each.

02

Approve the plan

Asthra maps each Appendix A subsection to its source data and proposes the reference safety information. Approve once.

03

Generate the first draft

Asthra drafts each subsection, reconciling toxicology margins with human exposure and keeping adverse-event terms consistent. Gaps surface where data is missing.

04

Writer review in Word

Refine the risk summary, regenerate a summary table, or check the RSI against the body in the task pane. Every change is logged.

05

Hand off & version forward

The draft ships with the audit ledger embedded. The next edition reuses the structured state — composed, not copy-pasted.

Manual vs. Asthra

What changes for the medical writing team.

Manual IB drafting

  • Toxicology and human PK reconciled by hand across distant sections
  • Adverse-event terminology drifts between the body and the RSI
  • Summary tables rebuilt manually from source reports
  • Each new version re-derived from the last by copy-paste
  • Regulatory-meeting changes hard to track across editions

IB drafting with Asthra

  • +Nonclinical and clinical findings synthesised in one pass
  • +Consistent MedDRA terms across the body and the reference safety information
  • +Summary tables generated from cited source data, auditable
  • +New editions composed from structured state, provenance carried forward
  • +Every claim resolves to a file, page, and passage on click

Pilot Asthra
on a real IB.

30-day pilot. Bring one compound. We'll match Asthra's brochure draft against your existing process — subsection by subsection.